| All ages | Ages < 2 | ||||||||||
Period | Overall | Outpatient | Inpatient | Overall | Outpatient | Inpatient | ||||||
 | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period |
Pre-PCV7 | 2,074 (2,051; 2,097) | – | 1,864 (1,842; 1,885) | – | 211 (203; 218) | – | 5,322 (5,197; 5,450) | – | 4,302 (4,190; 4,417) | – | 1,020 (967; 1,077) | – |
Early PCV7 | 2,006 (1,999; 2,013) | -3.3% | 1,825 (1,819; 1,832) | -2.1% | 181 (179; 183) | -13.8% | 4,788 (4,754; 4,823) | -10.0% | 3,975 (3,944; 4,007) | -7.6% | 813 (799; 828) | -20.3% |
Late PCV7 | 2,213 (2,208; 2,219) | 10.3% | 2,034 (2,029; 2,039) | 11.5% | 179 (178; 181) | -1.1% | 4,668 (4,642; 4,693) | -2.5% | 3,953 (3,929; 3,977) | -0.6% | 715 (705; 725) | -12.1% |
Early PCV13 | 2,238 (2,232; 2,243) | 1.1% | 2,103 (2,098; 2,109) | 3.4% | 134 (133; 136) | -25.1% | 4,232 (4,208; 4,257) | -9.3% | 3,700 (3,677; 3,723) | -6.4% | 533 (524; 541) | -25.5% |
Late PCV13 | 1,986 (1,981; 1,991) | -11.3% | 1,888 (1,883; 1,893) | -10.2% | 98 (97; 99) | -26.9% | 3,471 (3,449; 3,492) | -18.0% | 3,104 (3,083; 3,124) | -16.1% | 367 (360; 374) | -31.1% |
 | Ages 2–4 | Ages 5–17 | ||||||||||
 | Overall | Outpatient | Inpatient | Overall | Outpatient | Inpatient | ||||||
 | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period | IR (95% CI) | %Δ from prior period |
Pre-PCV7 | 4,012 (3,927; 4,099) | – | 3,652 (3,571; 3,734) | – | 361 (336; 387) | – | 1,383 (1,362; 1,404) | – | 1,287 (1,267; 1,307) | – | 96 (91; 102) | – |
Early PCV7 | 3,870 (3,846; 3,894) | -3.5% | 3,549 (3,526; 3,572) | -2.8% | 321 (314; 328) | -11.1% | 1,334 (1,328; 1,340) | -3.5% | 1,252 (1,246; 1,258) | -2.7% | 82 (80; 83) | -14.6% |
Late PCV7 | 4,152 (4,133; 4,171) | 7.3% | 3,841 (3,823; 3,859) | 8.2% | 311 (306; 316) | -3.1% | 1,546 (1,541; 1,551) | 15.9% | 1,455 (1,450; 1,460) | 16.2% | 90 (89; 92) | 11.0% |
Early PCV13 | 4,246 (4,227; 4,265) | 2.3% | 4,007 (3,989; 4,026) | 4.3% | 239 (234; 243) | -23.2% | 1,624 (1,619; 1,629) | 5.0% | 1,555 (1,550; 1,560) | 6.9% | 69 (68; 70) | -24.2% |
Late PCV13 | 3,794 (3,776; 3,812) | -10.6% | 3,614 (3,596; 3,631) | -9.8% | 180 (176; 184) | -24.7% | 1,475 (1,470; 1,480) | -9.2% | 1,423 (1,419; 1,428) | -8.5% | 51 (50; 52) | -26.1% |